These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 19526652)

  • 1. Statement on meningococcal vaccination for travellers. An Advisory Committee Statement (ACS).
    Committee to Advise on Tropical Medicine (CATMAT)
    Can Commun Dis Rep; 2009 Jun; 35(ACS-4):1-22. PubMed ID: 19526652
    [No Abstract]   [Full Text] [Related]  

  • 2. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 3. 2010 FIFA world cup South Africa: travel health issues and new options for protection against meningococcal disease.
    Zuckerman JN; Bröker M; Worth C
    Travel Med Infect Dis; 2010 Mar; 8(2):68-73. PubMed ID: 20478511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on meningococcal vaccination for travellers.
    Can Commun Dis Rep; 1999 Sep; 25():1-12. PubMed ID: 10765571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Advisory Committee Statement (ACS). Statement on recommended use of meningococcal vaccines.
    National Advisory Committee on Immunisation (NACI)
    Can Commun Dis Rep; 2001 Oct; 27():2-36. PubMed ID: 11706686
    [No Abstract]   [Full Text] [Related]  

  • 6. Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 May; 33(ACS-3):1-23. PubMed ID: 17520774
    [No Abstract]   [Full Text] [Related]  

  • 7. Meningococcal C conjugate vaccination recommendations for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Nov; 33(ACS-11):1-12. PubMed ID: 18064747
    [No Abstract]   [Full Text] [Related]  

  • 8. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Global spread of meningococcal serogroup W135].
    Vestergård D; David KP
    Ugeskr Laeger; 2008 Sep; 170(39):3044-7. PubMed ID: 18822228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability of meningococcal vaccine in single-dose vials for travelers and high-risk persons.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 Oct; 39(42):763. PubMed ID: 2120575
    [No Abstract]   [Full Text] [Related]  

  • 11. The risk of meningococcal disease in travelers and current recommendations for prevention.
    Steffen R
    J Travel Med; 2010; 17 Suppl():9-17. PubMed ID: 20849428
    [No Abstract]   [Full Text] [Related]  

  • 12. Statement on meningococcal vaccination for travellers. Committee to Advise on Tropical Medicine and Travel.
    CMAJ; 1995 Aug; 153(3):303-8. PubMed ID: 7614446
    [No Abstract]   [Full Text] [Related]  

  • 13. Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on meningococcal vaccination for travellers.
    Can Commun Dis Rep; 1995 Feb; 21(4):25-9. PubMed ID: 7735191
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningococcal disease and travel.
    Memish ZA
    Clin Infect Dis; 2002 Jan; 34(1):84-90. PubMed ID: 11731951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for control of meningococcal disease. The Advisory Committee on Epidemiology.
    Can Dis Wkly Rep; 1991 Nov; 17(45):245-50. PubMed ID: 1843653
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal disease and travel.
    Wilder-Smith A; Memish Z
    Int J Antimicrob Agents; 2003 Feb; 21(2):102-6. PubMed ID: 12615371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. W135 invasive meningococcal infections imported from Sub-Saharan Africa to France, January to April 2012.
    Parent du Chatelet I; Barboza P; Taha MK
    Euro Surveill; 2012 May; 17(21):. PubMed ID: 22687826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal disease control in countries of the African meningitis belt, 2013.
    Wkly Epidemiol Rec; 2014 May; 89(20):206-14. PubMed ID: 24864346
    [No Abstract]   [Full Text] [Related]  

  • 20. Meningococcal vaccine in travelers.
    Wilder-Smith A
    Curr Opin Infect Dis; 2007 Oct; 20(5):454-60. PubMed ID: 17762777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.